Global Hyperimmune Globulins Market Growth 2023-2029

Global Hyperimmune Globulins Market Growth 2023-2029

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

LPI (LP Information)' newest research report, the “Hyperimmune Globulins Industry Forecast” looks at past sales and reviews total world Hyperimmune Globulins sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperimmune Globulins sales for 2023 through 2029. With Hyperimmune Globulins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Globulins industry.

This Insight Report provides a comprehensive analysis of the global Hyperimmune Globulins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Globulins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyperimmune Globulins market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Globulins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Globulins.

The global Hyperimmune Globulins market size is projected to grow from US$ 1656.2 million in 2022 to US$ 2705.3 million in 2029; it is expected to grow at a CAGR of 2705.3 from 2023 to 2029.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Hepatitis B Immunoglobulins

Rabies Immunoglobulins

Tetanus Immunoglobulins

Rho(D) Immunoglobulins

Other

Segmentation by application

Government Institutions

Private Sector

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

CSL Behring

Grifols

Biotest

Kedrion

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

ADMA Biologics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hyperimmune Globulins market?

What factors are driving Hyperimmune Globulins market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hyperimmune Globulins market opportunities vary by end market size?

How does Hyperimmune Globulins break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.